{"version":"1.0","provider_name":"Times South Africa","provider_url":"https:\/\/timessouthafrica.com","author_name":"TSA","author_url":"https:\/\/timessouthafrica.com\/author\/tsa\/","title":"Adagio Therapeutics indique qu\u2019aucune des mutations pr\u00e9sentes dans Omicron, le variant du SARS-CoV-2, n\u2019est associ\u00e9e \u00e0 un \u00e9chappement de la neutralisation de l\u2019ADG20 in vitro - Times South Africa","type":"rich","width":600,"height":338,"html":"
Adagio Therapeutics indique qu\u2019aucune des mutations pr\u00e9sentes dans Omicron, le variant du SARS-CoV-2, n\u2019est associ\u00e9e \u00e0 un \u00e9chappement de la neutralisation de l\u2019ADG20 in vitro<\/a><\/blockquote>